US2023144853A1PendingUtilityA1
Topical compositions and methods of using the same
Est. expiryJun 19, 2037(~10.9 yrs left)· nominal 20-yr term from priority
A61K 8/9794A61K 8/368A61K 9/0014A61Q 19/00A61K 47/10A61K 8/8158A61K 8/42A61K 8/64A61K 8/345A61K 45/06A61K 8/34A61K 31/60A61K 8/44
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates generally to compositions and methods of using the same such as, for example, methods of treating the skin of a subject using a composition as described herein. The composition may comprise a diluent, a solvent, a penetration enhancing agent, a skin brightening agent, a skin renewing agent, a thickening agent, an anti-irritant, a chelating agent, an active pharmaceutical ingredient (API), optionally a pH adjustment agent, and optionally a preservative. The composition may further comprise L-arginine and/or L-citrulline and/or esters and/or derivatives thereof.
Claims
exact text as granted — not AI-modifiedThat which is claimed is:
1 . A method of treating a subject, the method comprising applying a composition comprising:
a diluent, wherein the diluent is water and water is present in an amount of about 60% to about 95% by weight of the topical composition; a solvent, wherein the solvent comprises an alcohol; a penetration enhancing agent, wherein the penetration enhancing agent comprises a glycol ether; a skin brightening agent, wherein the skin brightening agent comprises a first peptide; a skin renewal agent, wherein the skin renewal agent comprises a second peptide; a thickening agent, wherein the thickening agent comprises a polyacrylate polymer; an anti-irritant; a chelating agent; an active pharmaceutical ingredient (API) selected from the group consisting of salicylic acid, a nitric oxide (NO)-releasing compound, and any combination thereof; optionally a pH adjustment agent; and optionally a preservative.
2 . The method of claim 1 , wherein the composition further comprises L-arginine, esters thereof, or derivatives thereof; L-citrulline, esters therefor or derivatives thereof; or any combination thereof.
3 . The method of claim 1 , wherein the water is present in an amount of about 70% to about 90% by weight of the topical composition.
4 . The method of claim 1 , wherein the alcohol is tert-butyl alcohol.
5 . The method of claim 1 , wherein the solvent is present in an amount of about 1% to about 20% by weight of the topical composition.
6 . The method of claim 1 , wherein the glycol ether is ethoxydiglycol.
7 . The method of claim 1 , wherein the penetration enhancing agent is present in an amount of about 1% to about 10% by weight of the topical composition.
8 . The method of claim 1 , wherein the skin brightening agent is present in an amount of about 0.1% to about 10% by weight of the topical composition.
9 . The method of claim 1 , wherein the skin renewal agent is present in an amount of about 0.1% to about 10% by weight of the topical composition.
10 . The method of claim 1 , wherein the thickening agent is present in an amount of about 0.1% to about 5% by weight of the topical composition.
11 . The method of claim 1 , wherein the anti-irritant is present in an amount of about 0.1% to about 10% by weight of the topical composition.
12 . The method of claim 1 , wherein the chelating agent is present in an amount of about 0.01% to about 2% by weight of the topical composition.
13 . The method of claim 1 , wherein the API is salicylic acid.
14 . The method of claim 1 , wherein the API is present in an amount of about 0.1% to about 10% by weight of the topical composition.
15 . The method of claim 1 , wherein the topical composition further comprises the pH adjustment agent and the pH adjustment agent is present in an amount of about 0.01% to about 3% by weight of the topical composition.
16 . The method of claim 1 , wherein the topical composition further comprises the preservative and the preservative is present in an amount of about 0.01% to about 3% by weight of the topical composition.
17 . The method of claim 1 , wherein the API is a NO-releasing compound.Join the waitlist — get patent alerts
Track US2023144853A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.